Video

Davos 2019 - The Future of Healthcare w/ Ken Mulvany

Feb 4, 2019
HomeNEWSVideo
Davos 2019 - The Future of Healthcare w/ Ken Mulvany

Live from Davos at the World Economic Forum, CNBC’s Elizabeth Schulze hosts a fireside chat with our Founder, Ken Mulvany, discussing how BenevolentAI is disrupting the pharma industry and exploring what the future of healthcare could look like.

In 2018 BenevolentAI was named a Technology Pioneer by the World Economic Forum and participated to the World Economic Forum Annual Meeting of the New Champions, held in Tianjin, China where we discussed how using AI can help unlock the world’s most complex operating system - the human body.

Tagged:
Opinion
Receive our latest news
Featured Posts
News
BenevolentAI at NeurIPS 2020: Machine Learning in Drug Discovery
News
NIAID releases additional data validating BenevolentAI’s hypothesis for baricitinib as a treatment for COVID-19 patients in large-scale randomised control trial
News
BenevolentAI welcomes Professor Russ Altman as scientific advisor
Follow us
More Posts

You Might Also Like

Blog
Tech Nation Visa: the gateway to world-leading UK tech jobs
Drawing attention to the Tech Nation Visa, a great initiative that enables the brightest international talent to live and work in the UK.
Feb 19, 2021
News
BenevolentAI announces first patient dosed in its Atopic Dermatitis clinical trial
A molecule designed and developed by BenevolentAI to treat mild to moderate Atopic Dermatitis has entered clinical trials.
Feb 11, 2021
News
BenevolentAI and AstraZeneca achieve collaboration milestone with novel AI-generated chronic kidney disease target
BenevolentAI and AstraZeneca hit collaboration milestone with an AI-generated CKD target from the partnership entering AstraZeneca’s portfolio.
Jan 27, 2021
News
ACTT-2 trial results published in the New England Journal of Medicine validate baricitinib’s efficacy in combination with remdesivir in hospitalised COVID-19 patients
Peer-reviewed data from the ACTT-2 further validate BenevolentAI’s hypothesis for baricitinib as a potential COVID-19 treatment.
Jan 15, 2021
Blog
Joanna Shields speaks at the Global Partnership on Artificial Intelligence
BenevolentAI CEO Joanna Shields opened the final plenary of the Global Partnership on Artificial Intelligence (GPAI) summit with a powerful message on the future of AI.
Dec 11, 2020
Blog
BenevolentAI wins Innovation Award at 2020 Scrip Awards
BenevolentAI wins the Innovation Award at the prestigious 2020 Scrip Awards for our work in artificial intelligence applied drug discovery.
Dec 11, 2020
Drug programmescareersCOVID-19Data Diversity initiative
Contact us
Company Registration: 09781806
Terms & Conditions
Privacy & Cookies Policy